Related Experiment Video
Updated: Oct 25, 2025
05:34
5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
Published on: April 4, 2025
1.0K
[Analgesic Drug Therapy in Kidney Patients].
Deutsche Medizinische Wochenschrift (1946)
|August 3, 2021
Summary
Managing pain in kidney patients requires expertise due to frequent chronic pain and potential drug nephrotoxicity. Careful dosing of analgesics, including co-analgesics, and monitoring morphine metabolites are crucial to prevent adverse effects like respiratory depression.
Area of Science:
- Nephrology
- Pharmacology
- Pain Management
Background:
- Kidney disease patients frequently experience pain, often chronic.
- Analgesic medications carry a risk of nephrotoxicity.
- Co-analgesics (anticonvulsants, antidepressants, antipsychotics) require dose adjustment in renal impairment.
Purpose of the Study:
- To highlight the complexities of analgesic drug therapy in patients with kidney disease.
- To emphasize the need for specialized knowledge in managing pain in this population.
- To outline key considerations for safe and effective analgesic use in renal impairment.
Main Methods:
- Review of existing literature on analgesic use in renal disease.
- Analysis of pharmacokinetic considerations for common analgesics and co-analgesics.
- Examination of specific risks associated with morphine metabolites.
Main Results:
- Certain analgesics possess nephrotoxic potential, necessitating cautious selection.
- Dose adjustments for co-analgesics are essential based on kidney function.
- Accumulation of morphine-6-glucuronide in kidney patients increases the risk of respiratory depression.
Conclusions:
- Analgesic therapy in kidney patients demands specialized expertise and careful drug selection.
- Renal function must guide the dosing of analgesics and co-analgesics.
- Monitoring morphine metabolite kinetics is vital to mitigate risks like respiratory depression.
Related Concept Videos
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention
102
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
102
01:20Acute Kidney Injury V: Interprofessional Care
87
Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
87
01:28Chronic Kidney Disease III: Interprofessional Care
153
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
153
01:22Acute Kidney Injury VI: Nursing Management
139
Acute Kidney Injury (AKI) results in an inability to maintain fluid, electrolyte, and acid-base balance. Effective nursing management is critical in improving patient outcomes and includes comprehensive patient assessment and targeted interventions.Comprehensive Patient AssessmentA detailed history collection is essential, focusing on any recent infections, nephrotoxic medication use, or chronic conditions such as hypertension and diabetes that may contribute to AKI. During the physical...
139
01:25Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant
33
In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...
33
01:30Urinary Tract Calculi III: Medical Management
58
The diagnosis of renal calculi involves several imaging techniques, including non-contrast CT scans and ultrasound. These methods help visualize kidney stones, assess their size and location, and detect possible obstructions. Additionally, Measuring urine pH is useful for diagnosing specific stone types, such as struvite (alkaline pH) and uric acid stones (acidic pH). Cystine stones are primarily linked to cystinuria, a genetic condition. A urinalysis helps detect blood in the urine (hematuria)...
58